#ntla

Follow to get notified about new posts with this tag

nadzry

9y

Analyst outperform ratings on Crispr stocks.

Analyst outperform ratings on Crispr stocks.

Cowen, Barclays and ROTH all host healthcare conferences next week; • Intellia Therapeutics (NASDAQ:NTLA) initiated with Outperform rating and $76 (158% upside) price target at JMP Securities. • CRISPR

$ 0.000

0